Literature DB >> 29071387

[Ventricular arrhythmias : What has been confirmed in therapy?]

D Duncker1, J Bauersachs1, C Veltmann2.   

Abstract

Ventricular arrhythmias include a wide range of potentially benign single ventricular premature contractions to ventricular tachycardia and ventricular fibrillation with a risk for sudden cardiac death. The diagnosis of ventricular arrhythmia is made by 12-lead electrocardiogram, 24 h Holter monitoring, an external or implantable loop recorder, or during in-hospital monitoring. Especially the diagnosis of wide complex tachycardias is challenging in terms of differentiating between ventricular tachycardia and supraventricular tachycardia with aberrant atrioventricular conduction. After documentation of ventricular arrhythmias, diagnostic work-up with respect to structural or electrical cardiomyopathy is mandatory followed by risk stratification for sudden cardiac death. Therapeutic options for treatment of ventricular arrhythmias range from pharmacological therapy and interventional procedures such as catheter ablation and implantable devices. The current article provides an overview of the diagnosis of ventricular tachycardia and underlying cardiomyopathies. Furthermore, medical and interventional therapies are described. In addition, the indications for implantable and wearable defibrillators are presented.

Entities:  

Keywords:  Catheter ablation; Death, sudden, cardiac; Extrasystole, ventricular; Tachycardia, ventricular; Ventricular fibrillation

Mesh:

Substances:

Year:  2017        PMID: 29071387     DOI: 10.1007/s00108-017-0341-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  38 in total

Review 1.  Electrophysiology: Ventricular tachycardia: diagnosis of broad QRS complex tachycardia.

Authors:  H J Wellens
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

2.  Predictors of recovery of left ventricular dysfunction after ablation of frequent ventricular premature depolarizations.

Authors:  Marc W Deyell; Kyoung-Min Park; Yuchi Han; David S Frankel; Sanjay Dixit; Joshua M Cooper; Mathew D Hutchinson; David Lin; Fermin Garcia; Rupa Bala; Michael P Riley; Edward Gerstenfeld; David J Callans; Francis E Marchlinski
Journal:  Heart Rhythm       Date:  2012-05-26       Impact factor: 6.343

3.  Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study.

Authors:  Zhiyu Ling; Zengzhang Liu; Li Su; Vadim Zipunnikov; Jinjin Wu; Huaan Du; Kamsang Woo; Shaojie Chen; Bin Zhong; Xianbin Lan; Jinqi Fan; Yanping Xu; Weijie Chen; Yuehui Yin; Saman Nazarian; Bernhard Zrenner
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-02-12

4.  R-wave peak time at DII: a new criterion for differentiating between wide complex QRS tachycardias.

Authors:  Luis Fernando Pava; Pablo Perafán; Marisol Badiel; Juan José Arango; Lluis Mont; Carlos A Morillo; Josep Brugada
Journal:  Heart Rhythm       Date:  2010-03-04       Impact factor: 6.343

Review 5.  The Wearable Cardioverter/Defibrillator - Toy Or Tool?

Authors:  David Duncker; Christian Veltmann
Journal:  J Atr Fibrillation       Date:  2016-04-30

Review 6.  [New pharmacologic therapies for chronic heart failure].

Authors:  T Kempf; U Bavendiek; J Bauersachs
Journal:  Internist (Berl)       Date:  2017-09       Impact factor: 0.743

7.  Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.

Authors:  Lars Køber; Jens J Thune; Jens C Nielsen; Jens Haarbo; Lars Videbæk; Eva Korup; Gunnar Jensen; Per Hildebrandt; Flemming H Steffensen; Niels E Bruun; Hans Eiskjær; Axel Brandes; Anna M Thøgersen; Finn Gustafsson; Kenneth Egstrup; Regitze Videbæk; Christian Hassager; Jesper H Svendsen; Dan E Høfsten; Christian Torp-Pedersen; Steen Pehrson
Journal:  N Engl J Med       Date:  2016-08-27       Impact factor: 91.245

8.  Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.

Authors:  John L Sapp; George A Wells; Ratika Parkash; William G Stevenson; Louis Blier; Jean-Francois Sarrazin; Bernard Thibault; Lena Rivard; Lorne Gula; Peter Leong-Sit; Vidal Essebag; Pablo B Nery; Stanley K Tung; Jean-Marc Raymond; Laurence D Sterns; George D Veenhuyzen; Jeff S Healey; Damian Redfearn; Jean-Francois Roux; Anthony S L Tang
Journal:  N Engl J Med       Date:  2016-05-05       Impact factor: 91.245

9.  Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.

Authors:  David Duncker; Thorben König; Stephan Hohmann; Johann Bauersachs; Christian Veltmann
Journal:  J Am Heart Assoc       Date:  2017-01-17       Impact factor: 5.501

10.  Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysis.

Authors:  David Duncker; Ralf Westenfeld; Torsten Konrad; Tobias Pfeffer; Carlos A Correia de Freitas; Roman Pfister; Dierk Thomas; Alexander Fürnkranz; René P Andrié; Andreas Napp; Jörn Schmitt; Laszlo Karolyi; Reza Wakili; Denise Hilfiker-Kleiner; Johann Bauersachs; Christian Veltmann
Journal:  Clin Res Cardiol       Date:  2017-03-08       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.